SEC Form 4 · accession 0001140361-16-053835
BIOLASE, INC · BIOL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Period of report
Feb 16, 2016
Accepted (ET)
Feb 18, 2016 · 9:47 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000811240
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2,F1 | Feb 16, 2016 | P | 3,200 | $0.7981 | A | 6,546,137 | I | By Trust |
| Common StockF1 | Feb 17, 2016 | P | 900 | $0.80 | A | 6,547,037 | I | By Trust |
| Common Stock | holding | — | — | — | 14,800 | I | By spouse |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1These shares are held by the Jack W. Schuler Living Trust (the "Trust"). Mr. Schuler serves as sole trustee to the Trust.
- F2This price reflects the weighted average purchase price for open-market purchases of shares of Common Stock ("Shares") made by the Reporting Persons on February 16, 2016, within a $1.00 range. The actual prices for these transactions range from $0.798 to $0.80, inclusive. The Reporting Persons further undertake to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (2) to this Form 4.